Summary
Mahesh Nepal is a research scientist with over a decade of hands-on experience in early-phase clinical pharmacology, preclinical PK/ADME, and drug transporter biology, now applying that expertise at BioCryst Pharmaceuticals. He has authored 20+ peer-reviewed publications dissecting transporter-mediated drug uptake and toxicity mechanisms, particularly for anticancer agents and statins, and routinely combines in vitro, in vivo, and LC-MS/MS approaches to translate mechanistic findings into biomarker strategies. His work uniquely emphasizes identification of endogenous transporter substrates as potential functional biomarkers, bridging molecular pharmacology with clinically relevant safety and DDI risk assessment. Trained to PhD level and experienced across academic and industry settings, he also brings practical QA and method-development skills from earlier pharmaceutical roles. Based in Birmingham, AL, he is driven to advance collaborative, translational research that reduces toxicity without compromising therapeutic benefit.
10 years of coding experience
4 years of employment as a software developer
Bachelor's degree, Pharmacy, Bachelor's degree, Pharmacy at Kathmandu University (KU)
Kathmandu University, Bachelor of Pharmacy, Kathmandu University, Bachelor of Pharmacy at Bagmati Higher Secondary School
Bagmati Boarding School
Doctor of Philosophy - PhD, Pharmacy, A+, Doctor of Philosophy - PhD, Pharmacy, A+ at Yeungnam University
English, Nepali, Hindi, Korean